title: Multicenter pilot survey of resistant bacteria in the Mediterranean area.
abstract: With the aim of testing the feasibility of a multiresistant bacteria (MRB) surveillance methodology and evaluating the level of antimicrobial resistance and dissemination of resistant pathogens in the Mediterranean area, a pilot study was carried out in nine university hospitals in Algeria, Tunisia and France. The results indicate that third-generation cephalosporin-resistant Enterobacteriaceae comprise the major MRB in Algerian and Tunisian hospitals. In France, the highest incidence rates were found for methicillin-resistant Staphylococcus aureus, while in Tunisian hospitals, imipenem-resistant Acinetobacter baumannii seems to be a particularly prevalent organism. Although the data were not representative of the participating countries as a whole, the results show the importance and ubiquity of the problem in the area and the feasibility of surveillance.
authors.affiliation: Laboratoire d'Epidémiologie et Santé Publique, Université Claude Bernard Lyon I, 8 Avenue Rockefeller, 69373, Lyon, cedex 08, France. kamazian@sante.univ-lyon1.fr
authors.forename: K
authors.initials: K
authors.lastname: Amazian
authors.forename: C
authors.initials: C
authors.lastname: Fendri
authors.forename: M F K
authors.initials: MF
authors.lastname: Missoum
authors.forename: N
authors.initials: N
authors.lastname: Bouzouaia
authors.forename: K
authors.initials: K
authors.lastname: Rahal
authors.forename: A
authors.initials: A
authors.lastname: Savey
authors.forename: M
authors.initials: M
authors.lastname: Saadatian-Elahi
authors.forename: J
authors.initials: J
authors.lastname: Fabry
mesh_terms: D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000302:isolation & purification; D000462:Algeria; D003627:Data Interpretation, Statistical; D024901:Drug Resistance, Multiple, Bacterial; D004755:Enterobacteriaceae / Q000187:drug effects* / Q000302:isolation & purification; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D008712:Methicillin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D011446:Prospective Studies; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D014416:Tunisia
chemical_list: D008712:Methicillin